CircNRIP1 promotes proliferation, migration and phenotypic switch of Ang II-induced HA-VSMCs by increasing CXCL5 mRNA stability via recruiting IGF2BP1

References

• Zheng HQ, Rong JB, Ye FM, et al. Induction of thoracic aortic dissection: a mini-review of beta-aminopropionitrile-related mouse models. J Zhejiang Univ Sci B. 2020;21(8):1–10.
   PubMed Web of Science ®Google Scholar
• Saremi F, Hassani C, Lin LM, et al. Image predictors of treatment outcome after thoracic aortic dissection repair. Radiographics. 2018;38(7):1949–1972.
   PubMed Web of Science ®Google Scholar
• Sen I, Erben YM, Franco-Mesa C, et al. Epidemiology of aortic dissection. Semin Vasc Surg. 2021;34(1):10–17.
   PubMed Web of Science ®Google Scholar
• Cao G, Xuan X, Hu J, et al. How vascular smooth muscle cell phenotype switching contributes to vascular disease. Cell Commun Signal. 2022;20(1):180.
   PubMed Web of Science ®Google Scholar
• Fernández-Villabrille S, Martín-Carro B, Martín-Vírgala J, et al. Phosphorus may induce phenotypic transdifferentiation of vascular smooth muscle cells through the reduction of microRNA-145. Nutrients. 2023;15(13):2918.
   PubMed Web of Science ®Google Scholar
• Shi J, Yang Y, Cheng A, et al. Metabolism of vascular smooth muscle cells in vascular diseases. Am J Physiol Heart Circ Physiol. 2020;319(3):H613–H631.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zhao S, Han X, et al. Lnc-C2orf63-4-1 confers VSMC homeostasis and prevents aortic dissection formation via STAT3 interaction. Front Cell Dev Biol. 2021;9:792051.
   PubMed Web of Science ®Google Scholar
• Yang Y, Jiao X, Li L, et al. Increased circulating Angiopoietin-Like protein 8 levels are associated with thoracic aortic dissection and higher inflammatory conditions. Cardiovasc Drugs Ther. 2020;34(1):65–77.
   PubMed Web of Science ®Google Scholar
• Li Y, Chen J, Xie M, et al. Identification of a circRNA-miRNA-mRNA network to explore the effects of circRNAs on renal injury in systemic lupus erythematosus. Autoimmunity. 2023;56(1):2193361.
   PubMed Web of Science ®Google Scholar
• Mei HY, Liu J, Shen XP, et al. A novel circRNA, circRACGAP1, hampers the progression of systemic lupus erythematosus via miR-22-3p-mediated AKT signalling. Autoimmunity. 2022;55(6):360–370.
   PubMed Web of Science ®Google Scholar
• Wang F, Zhang F, Tian Q, et al. CircVMA21 ameliorates lipopolysaccharide (LPS)-induced HK-2 cell injury depending on the regulation of miR-7-5p/PPARA. Autoimmunity. 2022;55(2):136–146.
   PubMed Web of Science ®Google Scholar
• Zhang X, Lu J, Zhang Q, et al. CircRNA RSF1 regulated ox-LDL induced vascular endothelial cells proliferation, apoptosis and inflammation through modulating miR-135b-5p/HDAC1 axis in atherosclerosis. Biol Res. 2021;54(1):11.
   PubMed Web of Science ®Google Scholar
• Ding S, Zhu Y, Liang Y, et al. Circular RNAs in vascular functions and diseases. Adv Exp Med Biol. 2018;1087:287–297.
   PubMed Web of Science ®Google Scholar
• Zou M, Huang C, Li X, et al. Circular RNA expression profile and potential function of hsa_circRNA_101238 in human thoracic aortic dissection. Oncotarget. 2017;8(47):81825–81837.
   PubMedGoogle Scholar
• Xu Z, Zhong K, Guo G, et al. Circ_TGFBR2 inhibits vascular smooth muscle cells phenotypic switch and suppresses aortic dissection progression by sponging miR-29a. J Inflamm Res. 2021;14:5877–5890.
   PubMed Web of Science ®Google Scholar
• Zhou SL, Dai Z, Zhou ZJ, et al. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology. 2012;56(6):2242–2254.
   PubMed Web of Science ®Google Scholar
• Metzemaekers M, Mortier A, Vacchini A, et al. Endogenous modification of the chemoattractant CXCL5 alters receptor usage and enhances its activity toward neutrophils and monocytes. Sci Signal. 2021;14(673):eaax3053.
   PubMed Web of Science ®Google Scholar
• Moore CM, O’Reilly D, McCallion N, et al. Changes in inflammatory proteins following platelet transfusion in a neonatal population. Pediatr Res. 2023;94(6):1973–1977.
   PubMedGoogle Scholar
• Karaaslan Z, Yilmaz V, Yuceer H, et al. Serum CXCL5 as a biomarker in multiple sclerosis and neuromyelitis optica spectrum disorder. North Clin Istanb. 2023;10:341–344.
   PubMed Web of Science ®Google Scholar
• Cao Q, Chen J, Zhang Z, et al. Astrocytic CXCL5 hinders microglial phagocytosis of myelin debris and aggravates white matter injury in chronic cerebral ischemia. J Neuroinflammation. 2023;20(1):105.
   PubMed Web of Science ®Google Scholar
• Chang TT, Liao LY, Chen JW. Inhibition on CXCL5 reduces aortic matrix metalloproteinase 9 expression and protects against acute aortic dissection. Vascul Pharmacol. 2021;141:106926.
   PubMed Web of Science ®Google Scholar
• Goldfinger JZ, Halperin JL, Marin ML, et al. Thoracic aortic aneurysm and dissection. J Am Coll Cardiol. 2014;64(16):1725–1739.
   PubMed Web of Science ®Google Scholar
• Zhi K, Yin R, Guo H, et al. PUM2 regulates the formation of thoracic aortic dissection through EFEMP1. Exp Cell Res. 2023;427(2):113602.
   PubMedGoogle Scholar
• An Z, Liu Y, Song ZG, et al. Mechanisms of aortic dissection smooth muscle cell phenotype switch. J Thorac Cardiovasc Surg. 2017;154(5):1511–1521.e6. e1516.
   PubMed Web of Science ®Google Scholar
• Liang Q, Zhou Z, Li H, et al. Identification of pathological-related and diagnostic potential circular RNAs in Stanford type a aortic dissection. Front Cardiovasc Med. 2022;9:1074835.
   PubMed Web of Science ®Google Scholar
• Xie X, Hong X, Hong S, et al. Progression of thoracic aortic dissection is aggravated by the hsa_circ_0007386/miR-1271-5P/IGF1R/AKT axis via induction of arterial smooth muscle cell apoptosis. Biomedicines. 2023;11(2):571.
   PubMed Web of Science ®Google Scholar
• Sun N, Chu B, Choi DH, et al. ETV2 enhances CXCL5 secretion from endothelial cells, leading to the promotion of vascular smooth muscle cell migration. Int J Mol Sci. 2023;24(12):9904.
   PubMed Web of Science ®Google Scholar
• Jiang X, Liu B, Nie Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.
   PubMed Web of Science ®Google Scholar
• Xie F, Huang C, Liu F, et al. CircPTPRA blocks the recognition of RNA N(6)-methyladenosine through interacting with IGF2BP1 to suppress bladder cancer progression. Mol Cancer. 2021;20(1):68.
   PubMed Web of Science ®Google Scholar
• Lv J, Li K, Yu H, et al. HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway. J Exp Clin Cancer Res. 2023;42(1):41.
   PubMed Web of Science ®Google Scholar
• Peng W, Ye L, Xue Q, et al. Silencing of circCRIM1 drives IGF2BP1-Mediated NSCLC immune evasion. Cells. 2023;12(2):273.
   PubMed Web of Science ®Google Scholar
• Chen M, Tian B, Hu G, et al. METTL3-Modulated circUHRF2 promotes colorectal cancer stemness and metastasis through increasing DDX27 mRNA stability by recruiting IGF2BP1. Cancers (Basel). 2023;15(12):3148.
   PubMed Web of Science ®Google Scholar